ATE247832T1 - Reagenzien zum gebrauch als kalibratoren und kontrollen - Google Patents

Reagenzien zum gebrauch als kalibratoren und kontrollen

Info

Publication number
ATE247832T1
ATE247832T1 AT97903076T AT97903076T ATE247832T1 AT E247832 T1 ATE247832 T1 AT E247832T1 AT 97903076 T AT97903076 T AT 97903076T AT 97903076 T AT97903076 T AT 97903076T AT E247832 T1 ATE247832 T1 AT E247832T1
Authority
AT
Austria
Prior art keywords
calibrators
controls
antibodies
reagent
standards
Prior art date
Application number
AT97903076T
Other languages
English (en)
Inventor
John R Hackett Jr
Jane A Hoff
David H Ostrow
Alan M Golden
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE247832T1 publication Critical patent/ATE247832T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97903076T 1996-01-23 1997-01-17 Reagenzien zum gebrauch als kalibratoren und kontrollen ATE247832T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/589,939 US6015662A (en) 1996-01-23 1996-01-23 Reagents for use as calibrators and controls
PCT/US1997/001074 WO1997027486A1 (en) 1996-01-23 1997-01-17 Reagents for use as calibrators and controls

Publications (1)

Publication Number Publication Date
ATE247832T1 true ATE247832T1 (de) 2003-09-15

Family

ID=24360201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903076T ATE247832T1 (de) 1996-01-23 1997-01-17 Reagenzien zum gebrauch als kalibratoren und kontrollen

Country Status (8)

Country Link
US (1) US6015662A (de)
EP (1) EP1018019B1 (de)
JP (1) JP3486418B2 (de)
AT (1) ATE247832T1 (de)
CA (1) CA2243943C (de)
DE (1) DE69724292T2 (de)
ES (1) ES2205169T3 (de)
WO (1) WO1997027486A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015662A (en) 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7790856B2 (en) * 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US20080050367A1 (en) * 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US7026446B1 (en) 1997-12-24 2006-04-11 Diatech Pty Ltd. Bifunctional molecules
SE9704933D0 (sv) 1997-12-30 1997-12-30 Pharmacia & Upjohn Diag Ab Metod som utnyttjar en ny kalibrator och test kit som innehåller kalibratorn
US6908770B1 (en) * 1998-07-16 2005-06-21 Board Of Regents, The University Of Texas System Fluid based analysis of multiple analytes by a sensor array
US7011940B1 (en) 1999-04-14 2006-03-14 Medical Discovery Partners Llc Quality control for cytochemical assays
US20010046496A1 (en) * 2000-04-14 2001-11-29 Brettman Lee R. Method of administering an antibody
UY26317A1 (es) * 2000-08-30 2000-10-31 Alfonso Cayota Carlos Pritsch Sistema de produccion de trombopoyetina humana por celulas de mamiferos en cultivo
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
US7700751B2 (en) * 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
MY139983A (en) * 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
US20030203412A1 (en) * 2002-04-26 2003-10-30 Aristo Vojdani Immunoassay for detection of antibodies for molds and mycotoxins
NZ567324A (en) * 2003-02-01 2009-08-28 Wyeth Corp Active immunization to generate antibodies to soluble A-beta
WO2005065239A2 (en) * 2003-12-31 2005-07-21 Centocor, Inc. Novel recombinant proteins with n-terminal free thiol
US8105849B2 (en) * 2004-02-27 2012-01-31 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements
US8101431B2 (en) * 2004-02-27 2012-01-24 Board Of Regents, The University Of Texas System Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
US7625560B2 (en) * 2004-12-15 2009-12-01 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
EP1838348B1 (de) * 2004-12-15 2013-06-26 Janssen Alzheimer Immunotherapy Humanisierte amyloid-beta-antikörper zur verbesserung der kognition
WO2007053186A2 (en) 2005-05-31 2007-05-10 Labnow, Inc. Methods and compositions related to determination and use of white blood cell counts
EP1899450A4 (de) * 2005-06-24 2010-03-24 Univ Texas Systeme und verfahren einschliesslich in sich geschlossener kassetten mit nachweissystemen und flüssigkeitszufuhrsystemen
WO2007005666A2 (en) * 2005-07-01 2007-01-11 Board Of Regents, The University Of Texas System System and method of analyte detection using differential receptors
US20070014789A1 (en) * 2005-07-15 2007-01-18 Bayer Healthcare Llc Humanized antibody conjugates and related methods, assays, reagents, and kits
EP1922412A4 (de) * 2005-07-15 2009-07-15 Siemens Healthcare Diagnostics Humanisierte antikörperkonjugate und entsprechende verfahren, tests, reagenzien und kits
US8741260B2 (en) * 2005-10-07 2014-06-03 Armagen Technologies, Inc. Fusion proteins for delivery of GDNF to the CNS
EP1948691A1 (de) * 2005-11-17 2008-07-30 Millennium Pharmaceuticals, Inc. MIT a4ß7-INTEGRIN REAGIERENDES HUMANISIERTES IMMUNOGLOBULIN
US20070141723A1 (en) * 2005-12-16 2007-06-21 Sompuram Seshi A Immunohistochemistry staining controls
US8784810B2 (en) * 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8022188B2 (en) * 2006-04-24 2011-09-20 Abbott Laboratories Immunosuppressant binding antibodies and methods of obtaining and using same
US8759297B2 (en) * 2006-08-18 2014-06-24 Armagen Technologies, Inc. Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
US7858752B2 (en) 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
US20080300798A1 (en) * 2007-04-16 2008-12-04 Mcdevitt John T Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
US20080292625A1 (en) * 2007-04-18 2008-11-27 Sally Schroeter Prevention and treatment of cerebral amyloid angiopathy
US8003097B2 (en) * 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
AU2008282496B2 (en) 2007-07-27 2013-04-04 Armagen Technologies, Inc. Methods and compositions for increasing alpha-iduronidase activity in the CNS
DK2182983T3 (da) * 2007-07-27 2014-07-14 Janssen Alzheimer Immunotherap Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
JO3076B1 (ar) * 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US20090203037A1 (en) * 2007-12-27 2009-08-13 Abbott Laboratories Anti-T. Cruzi Antibodies and Methods of Use
WO2009124378A1 (en) * 2008-04-07 2009-10-15 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Chimeric anti-measles antibody
US20100009389A1 (en) * 2008-07-14 2010-01-14 Masood Unnabi Khan Method of Making and Using Versatile Positive Controls and Antibody Detection Assays
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
CA2748889A1 (en) 2009-03-18 2010-09-23 Armagen Technologies, Inc. Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
US8916154B2 (en) 2009-04-27 2014-12-23 Abbott Laboratories Antibodies against delta-5 desaturase and uses thereof
CA2767570C (en) * 2009-07-13 2018-05-01 Universite De Montreal Mutated sumo isoforms and uses thereof
WO2011031317A2 (en) * 2009-09-10 2011-03-17 The Board Of Regents Of The University Of Texas System Vaccine for control of trypanosoma cruzi infection and chagas disease
EP2485761B1 (de) 2009-10-09 2019-02-27 Armagen, Inc. Verfahren und zusammensetzungen für erhöhte iduronat-2-sulfatase-aktivität im zns
DE102009047243A1 (de) 2009-11-27 2011-06-01 Orgentec Diagnostika Gmbh Monospezifische Polypeptidreagenzien
ES2678145T3 (es) 2010-08-24 2018-08-09 Abbott Laboratories Anticuerpos específicos contra la proteína del núcleo del VIH y usos de los mismos
MX367097B (es) 2011-05-02 2019-08-05 Millennium Pharm Inc FORMULACION PARA ANTICUERPO ANTI-A4ß7.
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
AU2012309203B2 (en) * 2011-09-14 2017-08-10 Phadia Ab Calibration reagent and method
AU2012346448B2 (en) 2011-12-02 2017-09-14 Armagen, Inc. Methods and compositions for increasing arylsulfatase A activity in the CNS
WO2014026054A2 (en) * 2012-08-10 2014-02-13 University Of Southern California CD20 scFv-ELPs METHODS AND THERAPEUTICS
EP2893041A4 (de) * 2012-09-05 2016-07-06 Bio Rad Laboratories Chimärer anti-dsdna-/chromatin-antikörper
CA2970478A1 (en) 2014-12-10 2016-06-16 S-Aima Holding Company, Llc Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides
US10538589B2 (en) 2015-01-14 2020-01-21 Armagen Inc. Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
SE538541C2 (en) 2015-01-19 2016-09-13 Fogelstrand Per Method for preparing a biological sample for use in an immunolabeling process
CN107209176B (zh) 2015-01-21 2020-08-14 克罗姆尼贡公司 免疫标记复合物的形成方法及用途
CN105628941B (zh) * 2015-12-22 2017-09-22 北京康彻思坦生物技术有限公司 一种IgM血清学检测质控物的制备方法
US11753682B2 (en) 2016-03-07 2023-09-12 Father Flanagan's Boys'Home Noninvasive molecular controls
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
CN109112113B (zh) * 2018-09-05 2023-01-10 四川安可瑞新材料技术有限公司 抗人IgG的单克隆抗体、杂交瘤细胞株、试剂盒及其应用
CN112485455B (zh) * 2020-12-09 2022-11-01 深圳市亚辉龙生物科技股份有限公司 新冠病毒抗体质控品及其制备方法
CN112881716A (zh) * 2021-01-18 2021-06-01 北京贝尔生物工程股份有限公司 一种阳性组合质控品，其制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292403A (en) * 1978-08-24 1981-09-29 Akzona Incorporated Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins
DE3112334A1 (de) * 1981-03-28 1982-10-07 Behringwerke Ag, 3550 Marburg "kuenstliche kontroll- und standardseren, verfahren zu ihrer herstellung und ihre verwendung"
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
GB8422238D0 (en) * 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
EP0216846B2 (de) * 1985-04-01 1995-04-26 Celltech Limited Transformierte myeloma-zell-linie und dieselbe verwendendes verfahren zur expression eines gens, das ein eukaryontisches polypeptid kodiert
US5447837A (en) * 1987-08-05 1995-09-05 Calypte, Inc. Multi-immunoassay diagnostic system for antigens or antibodies or both
US5008183A (en) * 1988-05-10 1991-04-16 Bio-Research Laboratories, Inc. Assay system for detecting antibody and a method of producing non-human immune antibody
CA2027108A1 (en) * 1989-02-10 1990-08-11 Kenji Hosoda Method of immunological assaying of human osteocalcin, reagent and kit therefor, antibody to human osteocalcin, hybridoma producing said antibody, and method of producing it
US5183735A (en) * 1989-02-27 1993-02-02 Reaads Medical Products, Inc. Method and diagnostic test kit for detection of anti-dsDNA antibodies
EP0429218A1 (de) * 1989-11-17 1991-05-29 Baxter Diagnostics Inc. Antikörper von nichtmenschlichen Primaten zum Gebrauch als positive Kontrolle für Immunglobulinbestimmungen
DK138090D0 (da) * 1990-06-06 1990-06-06 Novo Nordisk As Diagnostisk analysemetode
DE4133945A1 (de) * 1991-10-14 1993-04-15 Behringwerke Ag Kuenstliche standard- und kontrollseren, verfahren zu ihrer herstellung und ihre verwendung
US5447838A (en) * 1992-08-05 1995-09-05 Hybritech Incorporated Protein-dye conjugate for confirmation of correct dilution of calibrators
US5462852A (en) * 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay
US6015662A (en) 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls

Also Published As

Publication number Publication date
CA2243943C (en) 2007-11-20
US6015662A (en) 2000-01-18
JP3486418B2 (ja) 2004-01-13
EP1018019A1 (de) 2000-07-12
DE69724292T2 (de) 2004-06-17
CA2243943A1 (en) 1997-07-31
JP2000505543A (ja) 2000-05-09
WO1997027486A1 (en) 1997-07-31
EP1018019B1 (de) 2003-08-20
ES2205169T3 (es) 2004-05-01
DE69724292D1 (de) 2003-09-25

Similar Documents

Publication Publication Date Title
DE69724292D1 (de) Reagenzien zum gebrauch als kalibratoren und kontrollen
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
DE69624920D1 (de) Testreagentien und Testvorrichtungen
JP6713478B2 (ja) Ｐｉｖｋａ−ｉｉの測定方法、及びｐｉｖｋａ−ｉｉ免疫測定試薬又はキットの製造方法
DE602004024236D1 (en) Assay
DE3779704D1 (de) Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten.
ATE184108T1 (de) Mca prüfung/kit zum nachweis von metallkationen
ATE51449T1 (de) Immunchemisches messverfahren fuer haptene und proteine.
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
DE50210021D1 (de) Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
ATE403866T1 (de) Verfahren zum nachweis von antikörpern in flüssigen proben
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
GR3018715T3 (en) Immunological detection method
EP1258729A3 (de) Verfahren zur Auswahl eines Antikörpers, einer Hybridomzelle, eines monoklonalen Antikörpers und seine Verwendung
DE69522021D1 (de) Monoklonaler Antikörper und seine Verwendung in einem Immunoassay
DE60037115D1 (de) Diagnostischer test für menschlisches matrix gla-protein und seine verwendung als biomarker
CA2434694A1 (en) Detection and quantification of cripto-1
DE10190630D2 (de) Verfahren zum Nachweis von Helicobacter Pylori und Heilmanii in Stuhl- und Speichelproben und Biopsiematerial
ATE493662T1 (de) Diagnostischer test für menschliches matrix gla- protein und seine verwendung als biomarker
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
AU2001250470A1 (en) Novel antibodies specifically identifying inactive psa, and uses thereof
CA2342199A1 (en) Monoclonal antibodies against s100

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1018019

Country of ref document: EP

REN Ceased due to non-payment of the annual fee